Login
Register
Submit a Paper
Propose a Special lssue
Open Access
ARTICLE
Cyclic nucleotide phosphodiesterase inhibition increases tyrosine phosphorylation and hyper motility in normal and pathological human spermatozoa
The Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA. USA.
Address correspondence to: Dr. Roberto Yunes. Area de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, CC 33, (5500) Mendoza, ARGENTINA. Fax: (+54-261) 449 4047. E-mail: ryunes@fcm.uncu.edu.ar
BIOCELL 2005, 29(3), 287-293. https://doi.org/10.32604/biocell.2005.29.287
Download PDFAbstract
Our objective was to determine the effect of phosphodiesterase (PDE) inhibition on: 1) tyrosine phosphorylation of human spermatozoa at the tail level; and 2) sperm motion parameters and hyperactivated motility. The study was conducted with normozoospermic and asthenozoospermic samples incubated under in vitro capacitating conditions. The main outcome measures were computer-assisted sperm motion analysis and fluorescent immunodetection of phosphotyrosine-containing proteins. Pentoxifylline (PTX) was used as PDE inhibitor because of its wide use in the clinic. PTX-treatment significantly increased sperm velocity, hyperactivated motility and tyrosine-phosphorylation, both in normo and asthenozoospermic samples. Tyrosine-phosphorylation of tail proteins was highly conspicuous in both types of samples, showing no differential pattern after PTX-treatment. Normozoospermic samples treated with pentoxifylline showed an increase in the number of spermatozoa displaying hyperactivated movement and tyrosine-phosphorylation at the tail level. Preliminary data on asthenozoospermic samples exhibiting altered motion characteristics and defective phosphorylation of sperm-tail proteins showed that both defects can be concomitantly overcome by pentoxifylline treatment. Tyrosine-phosphorylation of sperm-tail proteins is underlying the enhancement of hyperactivated motility resulting from PDE inhibition by pentoxifylline.Keywords
Cite This Article
APA Style
YUNES, R., FERNÁNDEZ, P., DONCEL, G.F., ACOSTA, A.A. (2005). Cyclic nucleotide phosphodiesterase inhibition increases tyrosine phosphorylation and hyper motility in normal and pathological human spermatozoa. BIOCELL, 29(3), 287-293. https://doi.org/10.32604/biocell.2005.29.287
Vancouver Style
YUNES R, FERNÁNDEZ P, DONCEL GF, ACOSTA AA. Cyclic nucleotide phosphodiesterase inhibition increases tyrosine phosphorylation and hyper motility in normal and pathological human spermatozoa. BIOCELL . 2005;29(3):287-293 https://doi.org/10.32604/biocell.2005.29.287
IEEE Style
R. YUNES, P. FERNÁNDEZ, G.F. DONCEL, and A.A. ACOSTA, “Cyclic nucleotide phosphodiesterase inhibition increases tyrosine phosphorylation and hyper motility in normal and pathological human spermatozoa,” BIOCELL , vol. 29, no. 3, pp. 287-293, 2005. https://doi.org/10.32604/biocell.2005.29.287
Citations
Copyright © 2005 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
